SILENT-2 Study
| Title: | Incidence of silent atrial fibrillation in patients with clinically silent brain ischemic lesions (SILENT2). |
| Short summary: | This multi-centre study aims to assess the cumulative incidence of Atrial Fibrillation (AF) diagnosis, a well-recognised cause for cryptogenic Acute Ischemic Stroke (AIS), at 24 months in patients with Silent Brain Infarction (SBI). The main hypothesis is that continuous rhythm monitoring will yield a similar incidence of AF diagnosis in patients with SBI as compared to patients with cryptogenic AIS. |
| Study design: | Prospective, multi-centre, investigator-initiated observational, cohort study. |
| Status: | ongoing |
| PI or Local PI: | Project Leader: PD Dr. med. Laurent Roten, Department of Cardiology, Inselspital Co-project Leader: Prof. Dr. med. Urs Fischer, Department of Neurology, University Hospital Basel Local Project Leader: Prof. Dr. med. Michael Kuehne, Department of Cardiology |
| Link: |